Evaluate provides trusted commercial intelligence for the pharmaceutical industry. We help our clients to re昀椀ne and transform their understanding of the past, present and future of the global pharmaceutical market to drive better decisions. When you partner with Evaluate, our constantly expanding solutions and our transparent methodologies and datasets are instantly at your disposal, along with personalised, expert support. Evaluate gives you the time and con昀椀dence to turn understanding into insight, and insight into action. o昀昀ers a global view of the pharmaceutical market’s past, present and future performance with consensus forecasts to 2024, company 昀椀nancials, pipelines and deals. @EvaluatePharma provides the 昀椀rst single view of the risk and reward of the R&D landscape with consensus forecasts, R&D costs at drug and trial level, success rates, predictive timelines and trial outcomes. tracks, benchmarks, and forecasts global performance for the medical device and diagnostic industry with consensus forecasts to 2024, company 昀椀nancials and more. improves your strategic decision-making with customised solutions and deep insights that draw on our industry expertise and trusted commercial intelligence. provides award-winning, thought-provoking news and insights into current and future developments in the industry, and is the only pharmaceutical news service underpinned by Evaluate’s commercial intelligence. @Vantageanalysis Discover more about ® EvaluatePharma Vision www.evaluate.com Evaluate Headquarters Evaluate Americas Evaluate Asia Paci昀椀c Evaluate Ltd. EvaluatePharma USA Inc. Evaluate Japan KK 11-29 Fashion Street 60 State Street, Suite 1910 Akasaka Garden City 4F London E1 6PX Boston, MA 02109 4-15-1 Akasaka, Minato-ku United Kingdom USA Tokyo 107-0052, Japan T +44 (0)20 7377 0800 T +1 617 573 9450 T +81 (0)80 1164 4754 JUNE 2019